,
Mounjaro is a highly effective weight loss treatment, shown in clinical trials to help achieve ~20% body weight loss. It is the latest GLP1 weight loss inection, and is used for people with a body mass index (BMI) over 30. It contains the drug tirzepatide and is a registered trademark of Eli Lilly. It is known as Zepbound in the US, but is launching in the UK under the brand name Mounjaro.
